1,194
Views
48
CrossRef citations to date
0
Altmetric
Review Article

Defects in cholesterol synthesis genes in mouse and in humans: lessons for drug development and safer treatments

, &
Pages 69-90 | Received 13 Oct 2010, Accepted 12 Nov 2010, Published online: 20 Jan 2011

References

  • Aboushadi, N., Shackelford, J. E., Jessani, N., Gentile, A., Krisans, S. K. (2000). Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition. Biochemistry 39:237–247.
  • Acimovic, J., Fink, M., Pompon, D., Bjorkhem, I., Hirayama, J., Sassone-Corsi, P., et al. (2008). CREM modulates the circadian expression of CYP51, HMGCR, and cholesterogenesis in the liver. Biochem Biophys Res Commun 376:206–210.
  • Acimovic, J., Lovgren-Sandblom, A., Monostory, K., Rozman, D., Golicnik, M., et al. (2009). Combined gas chromatographic/mass spectrometric analysis of cholesterol precursors and plant sterols in cultured cells. J Chromatogr B Analyt Technol Biomed Life Sci 877:2081–2086.
  • Aleck, K. A., Bartley, D. L. (1997). Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 72:253–256.
  • Andersson, H. C., Kratz, L., Kelley, R. (2002). Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. Am J Med Genet 113:315–319.
  • Arlt, W. (2007). P450 oxidoreductase deficiency and Antley-Bixler syndrome. Rev Endocr Metab Disord 8:301–307.
  • Bae, S-H., Paik, Y-K. (1997). Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol D24-reductase. Biochem. J. 326:609–616.
  • Barbu, V., Roux, C., Lambert, D., Dupuis, R., Gardette, J., Maziere, J. C., et al. (1988). Cholesterol prevents the teratogenic action of AY 9944: importance of the timing of cholesterol supplementation to rats. J Nutr 118:774–779.
  • Barthelmes, L., Gateley, C. A. (2004). Tamoxifen and pregnancy. Breast 13:446–451.
  • Belknap, W. M., Dietschy, J. M. (1988). Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. J Clin Invest 82:2077–2085.
  • Berthois, Y., Bourrie, B., Galiegue, S., Vidal, H., Carayon, P., Martin, P. M., et al. (2003). SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo. Br J Cancer 88:438–446.
  • Bitgood, M. J., Shen, L., McMahon, A. P. (1996). Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol 6:298–304.
  • Breitling, R., Krazeisen, A., Moller, G., Adamski, J. (2001). 17beta-hydroxysteroid dehydrogenase type 7—an ancient 3-ketosteroid reductase of cholesterogenesis. Mol Cell Endocrinol 171:199–204.
  • Breitling, R., Krisans, S. K. (2002). A second gene for peroxisomal HMG-CoA reductase? A genomic reassessment. J Lipid Res 43:2031–2036.
  • Brunetti-Pierri, N., Corso, G., Rossi, M., Ferrari, P., Balli, F., Rivasi, F., et al. (2002). Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase. Am J Hum Genet 71:952–958.
  • Buhaescu, I., Izzedine, H. (2007). Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 40:575–584.
  • Burke, K. T., Colvin, P. L., Myatt, L., Graf, G. A., Schroeder, F., Woollett, L. A. (2009). Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the golden Syrian hamster. J Lipid Res 50:1146–1155.
  • Caldas, H., Cunningham, D., Wang, X., Jiang, F., Humphries, L., Kelley, R. I., et al. (2005). Placental defects are associated with male lethality in bare patches and striated embryos deficient in the NAD(P)H Steroid Dehydrogenase-like (NSDHL) Enzyme. Mol Genet Metab 84:48–60.
  • Carstea, ED, Morris, JA, Coleman, KG, Loftus, SK, Zhang, D, Cummings, C, Gu, J, Rosenfeld, MA, Pavan, WJ, Krizman, DB, Nagle, J, Polymeropoulos, MH, Sturley, SL, Ioannou, YA, Higgins, ME, Comly, M, Cooney, A, Brown, A, Kaneski, CR, Blanchette-Mackie, EJ, Dwyer, NK, Neufeld, EB, Chang, TY, Liscum, L, Tagle, DA and et al. (1997). Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277:228–231.
  • Cases, S, Novak, S, Zheng, YW, Myers, HM, Lear, SR, Sande, E, Welch, CB, Lusis, AJ, Spencer, TA, Krause, BR, Erickson, SK, Farese, RV, Jr. (1998a). ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J Biol Chem 273:26755–64.
  • Cases, S, Smith, SJ, Zheng, YW, Myers, HM, Lear, SR, Sande, E, Novak, S, Collins, C, Welch, CB, Lusis, AJ, Erickson, SK, Farese, RV, Jr. (1998b). Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A 95:13018–23.
  • Cenedella, R. J., Sexton, P. S. (1998). Probing cataractogenesis associated with mevalonic aciduria. Curr Eye Res 17:153–158.
  • Chevy, F., Illien, F., Wolf, C., Roux, C. (2002). Limb malformations of rat fetuses exposed to a distal inhibitor of cholesterol biosynthesis. J Lipid Res 43:1192–1200.
  • Chiang, C., Litingtung, Y., Lee, E., Young, K. E., Corden, J. L., Westphal, H., et al. (1996). Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383:407–413.
  • Colnot, C., de la Fuente, L., Huang, S., Hu, D., Lu, C., St-Jacques, B., et al. (2005). Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development 132:1057–1067.
  • Cooper, M. K., Wassif, C. A., Krakowiak, P. A., Taipale, J., Gong, R., Kelley, R. I., et al. (2003). A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 33:508–513.
  • Correa-Cerro, L. S., Porter, F. D. (2005). 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab 84:112–126.
  • Cotman, M., Jezek, D., Fon Tacer, K., Frangez, R., Rozman, D. (2004). A functional cytochrome P450 lanosterol 14{alpha}-demethylase CYP51 enzyme in the acrosome: transport through the Golgi and synthesis of meiosis activating sterols. Endocrinology 145:1419–1426.
  • Cunningham, D., Talabere, T., Bir, N., Kennedy, M., McBride, K. L., Herman, G. E. (2010). Significant contributions of the extraembryonic membranes and maternal genotype to the placental pathology in heterozygous Nsdhl deficient female embryos. Hum Mol Genet 19:364–373.
  • Curry, C. J., Carey, J. C., Holland, J. S., Chopra, D., Fineman, R., Golabi, M., et al. (1987). Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am J Med Genet 26:45–57.
  • De Leo, L., Marcuzzi, A., Decorti, G., Tommasini, A., Crovella, S., Pontillo, A. (2010). Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 61:506–510.
  • de Lorgeril, M, Salen, P, Abramson, J, Dodin, S, Hamazaki, T, Kostucki, W, et al. (2010). Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal. Arch Intern Med 170:1032–1036.
  • Debeljak, N., Fink, M., Rozman, D. (2003). Many facets of mammalian lanosterol 14alpha-demethylase from the evolutionarily conserved cytochrome P450 family CYP51. Arch Biochem Biophys 409:159–171.
  • Debeljak, N., Horvat, S., Lee, M., Rozman, D. (2000). Characterization of the mouse lanosterol 14α-demethylase (Cyp51), a memebr of the evolutionarily most conserved cytochrome P450 family. Arch Biochem Biophys 379:37–45.
  • Derry, J. M., Gormally, E., Means, G. D., Zhao, W., Meindl, A., Kelley, R. I., et al. (1999). Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. Nat Genet 22:286–290.
  • Elsayed, R. K., Evans, J. D. (2008). Emerging lipid-lowering drugs: squalene synthase inhibitors. Exp Opin Emerg Drugs 13:309–322.
  • Erickson, R. P., Bhattacharyya, A., Hunter, R. J., Heidenreich, R. A., Cherrington, N. J. (2005). Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet. Am J Physiol Gastrointest Liver Physiol 289:G300–G307
  • Fernandez, C., Martin, M., Gomez-Coronado, D., Lasuncion, M. A. (2005). Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression. J Lipid Res 46:920–929.
  • Filler, R., Lew, K. J. (1981). Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos. Proc Natl Acad Sci U S A 78:6991–6995.
  • Fink, M., Acimovic, J., Rezen, T., Tansek, N., Rozman, D. (2005). Cholesterogenic lanosterol 14alpha-demethylase (CYP51) is an immediate early response gene. Endocrinology 146:5321–5331.
  • Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., et al. (1999). Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A 96:133–138.
  • Fitzky, BU, Witsch-Baumgartner, M, Erdel, M, Lee, JN, Paik, Y-K, Glossmann, H, Utermann, G, Moebius, F (1998). Mutations in the D7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc. Natl. Acad. Sci. USA 95:8181–8186.
  • Fitzky, B. U., Moebius, F. F., Asaoka, H., Waage-Baudet, H., Xu, L., Xu, G., et al. (2001). 7-dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest 108:905–915.
  • FitzPatrick, D. R., Keeling, J. W., Evans, M. J., Kan, A. E., Bell, J. E., Porteous, M. E., et al. (1998). Clinical phenotype of desmosterolosis. Am J Med Genet 75:145–152.
  • Fliesler, S. J., Peachey, N. S., Richards, M. J., Nagel, B. A., Vaughan, D. K. (2004). Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features. Arch Ophthalmol 122:1190–1200.
  • Fluck, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., et al. (2004). Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36:228–230.
  • Fon Tacer, K., Haugen, T. B., Baltsen, M., Debeljak, N., Rozman, D. (2002). Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis activation sterol T-MAS. J Lipid Res 43:82–89.
  • Fu, Z., Voynova, N. E., Herdendorf, T. J., Miziorko, H. M., Kim, J. J. (2008). Biochemical and structural basis for feedback inhibition of mevalonate kinase and isoprenoid metabolism. Biochemistry 47:3715–3724.
  • Fukami, M., Hasegawa, T., Horikawa, R., Ohashi, T., Nishimura, G., Homma, K., et al. (2006). Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res 59:276–280.
  • Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., et al. (2005). Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90:414–426.
  • Giera, M., Renard, D., Plossl, F., Bracher, F. (2008). Lathosterol side chain amides: a new class of human lathosterol oxidase inhibitors. Steroids 73:299–308.
  • Greeve, I., Hermans-Borgmeyer, I., Brellinger, C., Kasper, D., Gomez-Isla, T., Behl, C., et al. (2000). The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer′s disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345–7352.
  • Grinstead, GF, Gazlor, JL (1982). Total enyzmatic synthesis of cholesterol from 4,4,14a-trimethyl-5a-cholesta-8,24-dien-3b-ol. J. Biol. Chem. 257:13937–13944.
  • Guillen, N., Acin, S., Navarro, M. A., Perona, J. S., Arbones-Mainar, J. M., Arnal, C., et al. (2008). Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis 197:72–83.
  • Gylling, H., Pyrhonen, S., Mantyla, E., Maenpaa, H., Kangas, L., Miettinen, T. A. (1995). Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. J Clin Oncol 13:2900–2905.
  • Hager, E. J., Tse, H. M., Piganelli, J. D., Gupta, M., Baetscher, M., Tse, T. E., et al. (2007). Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome. J Inherit Metab Dis 30:888–895.
  • Halder, S., Fink, M., Waterman, M., Rozman, D. (2002). A cAMP responsive element binding site is essential for sterol regulation of the human lanosterol 14α−demethylase gene (CYP51). Mol Endocrinol 16:1853–1863.
  • Hamada, N., Ogawa, Y., Saibara, T., Murata, Y., Kariya, S., Nishioka, A., et al. (2000). Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment. Int J Oncol 17:1119–1123.
  • Hannoush, R. N., Sun, J. (2010). The chemical toolbox for monitoring protein fatty acylation and prenylation. Nat Chem Biol 6:498–506.
  • Haynes, B. P., Straume, A. H., Geisler, J., A′Hern, R., Helle, H., Smith, I. E., et al. (2010). Intratumoral estrogen disposition in breast cancer. Clin Cancer Res 16:1790–1801.
  • Herman, GE. (2000). X-linked dominant disorders of cholesterol biosynthesis in man and mouse. Biochim Biophys Acta 1529:357–373.
  • Herman, G. E. (2003). Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet 12:R75–R88
  • Heverin, M., Meaney, S., Brafman, A., Shafir, M., Olin, M., Shafaati, M., et al. (2007). Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler Thromb Vasc Biol 27:2191–2197.
  • Houten, S. M., Frenkel, J., Waterham, H. R. (2003). Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci 60:1118–1134.
  • Irons, M., Elias, E. R., Salen, G., Tint, G. S., Batta, A.K. (1994). Defective cholesterol synthesis in Smith-Lemli-Opitz syndrome. Lancet 341:1414.
  • Javitt, N. B. (2008). Oxysterols: novel biologic roles for the 21st century. Steroids 73:149–157.
  • Jiang, F., Herman, G. E. (2006). Analysis of Nsdhl-deficient embryos reveals a role for Hedgehog signaling in early placental development. Hum Mol Genet 15:3293–3305.
  • Jokela, H., Rantakari, P., Lamminen, T., Strauss, L., Ola, R., Mutka, A. L., et al. (2010). Hydroxysteroid (17beta) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos. Endocrinology 151:1884–1892.
  • Kawata, S, Trzaskos, JM, Gaylor, JL (1985). Microsomal enzymes of cholesterol biosynthesis from lanosterol. J. Biol. Chem. 260:6609–6617.
  • Kelley, R. I., Kratz, L. E., Glaser, R. L., Netzloff, M. L., Wolf, L. M., Jabs, E. W. (2002). Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am J Med Genet 110:95–102.
  • Koide, T., Hayata, T., Cho, K. W. (2006). Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase. Development 133:2395–2405.
  • Konig, A., Happle, R., Bornholdt, D., Engel, H., Grzeschik, K. H. (2000). Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet 90:339–346.
  • Korosec, T., Acimovic, J., Seliskar, M., Kocjan, D., Tacer, K. F., Rozman, D., et al. (2008). Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51). Bioorg Med Chem 16:209–221.
  • Krakowiak, P. A., Wassif, C. A., Kratz, L., Cozma, D., Kovarova, M., Harris, G., et al. (2003). Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum Mol Genet 12:1631–1641.
  • Laggner, C., Schieferer, C., Fiechtner, B., Poles, G., Hoffmann, R. D., Glossmann, H., et al. (2005). Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. J Med Chem 48:4754–4764.
  • Lamb, D. C., Kelly, D. E., Waterman, M. R., Stromstedt, M., Rozman, D., Kelly, S. L. (1999). Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. Yeast 15:755–763.
  • Lauth, M., Rohnalter, V., Bergstrom, A., Kooshesh, M., Svenningsson, P., Toftgard, R. (2010). Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Mol Pharmacol 78:486–496.
  • Lewis, P. M., Dunn, M. P., McMahon, J. A., Logan, M., Martin, J. F., St-Jacques, B., et al. (2001). Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 105:599–612.
  • Litingtung, Y., Lei, L., Westphal, H., Chiang, C. (1998). Sonic hedgehog is essential to foregut development. Nat Genet 20:58–61.
  • Liu, X. Y., Dangel, A. W., Kelley, R. I., Zhao, W., Denny, P., Botcherby, M., et al. (1999). The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase. Nat Genet 22:182–187.
  • Lucas, M. E., Ma, Q., Cunningham, D., Peters, J., Cattanach, B., Bard, M., et al. (2003). Identification of two novel mutations in the murine Nsdhl sterol dehydrogenase gene and development of a functional complementation assay in yeast. Mol Genet Metab 80:227–233.
  • Lupetti, A., Danesi, R., Campa, M., Del Tacca, M., Kelly, S. (2002). Molecular basis of resistance to azole antifungals. Trends Mol Med 8:76–81.
  • Mancini, J., Philip, N., Chabrol, B., Divry, P., Rolland, M. O., Pinsard, N. (1993). Mevalonic aciduria in 3 siblings: a new recognizable metabolic encephalopathy. Pediatr Neurol 9:243–246.
  • Manson, J. M., Freyssinges, C., Ducrocq, M. B., Stephenson, W. P. (1996). Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy. Reprod Toxicol 10:439–446.
  • Marijanovic, Z., Laubner, D., Moller, G., Gege, C., Husen, B., Adamski, J., et al. (2003). Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol Endocrinol 17:1715–1725.
  • Meiner, V. L., Cases, S., Myers, H. M., Sande, E. R., Bellosta, S., Schambelan, M., et al. (1996). Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A 93:14041–14046.
  • Mirza, R., Hayasaka, S., Kambe, F., Maki, K., Kaji, T., Murata, Y., et al. (2008). Increased expression of aquaporin-3 in the epidermis of DHCR24 knockout mice. Br J Dermatol 158:679–684.
  • Mirza, R., Hayasaka, S., Takagishi, Y., Kambe, F., Ohmori, S., Maki, K., et al. (2006). DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis. J Invest Dermatol 126:638–647.
  • Mirza, R., Qiao, S., Murata, Y., Seo, H. (2009). Requirement of DHCR24 for postnatal development of epidermis and hair follicles in mice. Am J Dermatopathol 31:446–452.
  • Moebius, F. F., Fitzky, B. U., Glossmann, H. (2000). Genetic defects in postsqualene cholesterol biosynthesis. Trends Endocrinol Metab 11:106–114.
  • Moebius, F. F., Reiter, R. J., Bermoser, K., Glossmann, H., Cho, S. Y., Paik, Y. K. (1998). Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil. Mol Pharmacol 54:591–598.
  • Moebius, F. F., Reiter, R. J., Hanner, M., Glossmann, H. (1997). High affinity of sigma1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol 121:1–6.
  • Monostory, K., Pascussi, J. M., Szabo, P., Temesvari, M., Kohalmy, K., Acimovic, J., et al. (2009). Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent. Drug Metab Dispos 37:375–385.
  • Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., et al. (2004). Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 24:29–50.
  • Napoli, C., D′Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., et al. (1997). Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100:2680–2690.
  • Napoli, C., Glass, C. K., Witztum, J. L., Deutsch, R., D′Armiento, F. P., Palinski, W. (1999). Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354:1234–1241.
  • Nimmo, M. R., Cross, N. L. (2003). Structural features of sterols required to inhibit human sperm capacitation. Biol Reprod 68:1308–1317.
  • O′Brien, W. T., Xu, G., Batta, A., Tint, G. S., Salen, G., Dyer, C. A., et al. (2002). Developmental sensitivity of associative learning to cholesterol synthesis inhibitors. Behav Brain Res 129:141–152.
  • Ohashi, K., Osuga, J., Tozawa, R., Kitamine, T., Yagyu, H., Sekiya, M., et al. (2003a). Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene. J Biol Chem 278:42936–42941.
  • Ohashi, M., Mizushima, N., Kabeya, Y., Yoshimori, T. (2003b). Localization of mammalian NAD(P)H steroid dehydrogenase-like protein on lipid droplets. J Biol Chem 278:36819–36829.
  • Okazaki, H., Tazoe, F., Okazaki, S., Isoo, N., Tsukamoto, K., Sekiya, M., et al. (2006). Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver. J Lipid Res 47:1950–1958.
  • Otto, D. M., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., et al. (2003). Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol Cell Biol 23:6103–6116.
  • Parent, N., Winstall, E., Beauchemin, M., Paquet, C., Poirier, G. G., Bertrand, R. (2009). Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells. J Proteomics 72:960–973.
  • Patel, C., Edgerton, L., Flake, D., Smits, A. (2006). Clinical inquiries. What precautions should we use with statins for women of childbearing age? J Fam Pract 55:75–77.
  • Paul, R., Silve, S., De Nys, N., Dupuy, P. H., Bouteiller, C. L., Rosenfeld, J., et al. (1998). Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomerase. J Pharmacol Exp Ther 285:1296–1302.
  • Pedretti, A., Bocci, E., Maggi, R., Vistoli, G. (2008). Homology modelling of human DHCR24 (seladin-1) and analysis of its binding properties through molecular docking and dynamics simulations. Steroids 73:708–719.
  • Pepicelli, C. V., Lewis, P. M., McMahon, A. P. (1998). Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol, 8, 1083–6.
  • Peri, A., Danza, G., Benvenuti, S., Luciani, P., Deledda, C., Rosati, F., et al. (2009). New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm. Front Neuroendocrinol 30:119–129.
  • Plosch, T., van Straten, E. M., Kuipers, F. (2007). Cholesterol transport by the placenta: placental liver X receptor activity as a modulator of fetal cholesterol metabolism? Placenta 28:604–610.
  • Porter, F. D. (2008). Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis, and management. Eur J Hum Genet 16:535–541.
  • Pursley, T. J., Blomquist, I. K., Abraham, J., Andersen, H. F., Bartley, J. A. (1996). Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 22:336–340.
  • Qiu, Y., Li, D. (2006). Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase. Org Lett 8:1013–1016.
  • Rakheja, D., Boriack, R. L. (2008). Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata. Pediatr Dev Pathol 11:128–132.
  • Rallidis, L. S., Lekakis, J., Kremastinos, D. T. (2007). Current questions regarding the use of statins in patients with coronary heart disease. Int J Cardiol 122:188–194.
  • Ramadori, G., Cameron, S. (2010). Effects of systemic chemotherapy on the liver. Ann Hepatol 9:133–143.
  • Repetto, M., Maziere, J. C., Citadelle, D., Dupuis, R., Meier, M., Biade, S., et al. (1990). Teratogenic effect of the cholesterol synthesis inhibitor, AY 9944, on rat embryos in vitro. Teratology 42:611–618.
  • Rezen, T., Debeljak, N., Kordis, D., Rozman, D. (2004). New aspects on lanosterol 14alpha-demethylase and cytochrome P450 evolution: lanosterol/cycloartenol diversification and lateral transfer. J Mol Evol 59:51–58.
  • Rezen, T., Rozman, D., Pascussi, JM., Monostory, K. (2011). Interplay between cholesterol and drug metabolism. Biochim Biophys Acta 1814:146–160.
  • Rossi, M., D′Armiento, M., Parisi, I., Ferrari, P., Hall, C. M., Cervasio, M., et al. (2007). Clinical phenotype of lathosterolosis. Am J Med Genet A 143A:2371–2381.
  • Rossi, M., Vajro, P., Iorio, R., Battagliese, A., Brunetti-Pierri, N., Corso, G., et al. (2005). Characterization of liver involvement in defects of cholesterol biosynthesis: long-term follow-up and review. Am J Med Genet A 132A:144–151.
  • Rozman, D., Fink, M., Fimia, G. M., Sassone-Corsi, P., Waterman, M. R. (1999). Cyclic adenosine 3′,5′-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids. Mol Endocrinol 13:1951–1962.
  • Rozman, D., Monostory, K. (2010). Perspectives of the non-statin hypolipidemic agents. Pharmacol Ther 127:19–40.
  • Rozman, D., Seliskar, M., Cotman, M., Fink, M. (2005). Pre-cholesterol precursors in gametogenesis. Mol Cell Endocrinol 234:47–56.
  • Rozman, D., Strömstedt, M., Tsui, L-C., Scherer, S. W., Waterman, M. R. (1996). Structure and mapping of the human lanosterol 14α-demethylase gene (CYP51) encoding the cytochrome P450 involved in cholesterol biosynthesis; comparison of exon/intron organization with other mammalian and fungal CYP genes. Genomics 38:371–381.
  • Rozman, D., Waterman, M. R. (1998). Lanosterol 14α−demethylase (CYP51) and spermatogenesis. Drug Metab Dispos 26:1199–1201.
  • Scharnagl, H., Marz, W. (2005). New lipid-lowering agents acting on LDL receptors. Curr Top Med Chem 5:233–242.
  • Schmid, K. E., Davidson, W. S., Myatt, L., Woollett, L. A. (2003). Transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from maternal to fetal circulation. J Lipid Res 44:1909–1918.
  • Schneiders, M. S., Houten, S. M., Turkenburg, M., Wanders, R. J., Waterham, H. R. (2006). Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. Arthr Rheum 54:2306–2313.
  • Seliskar, M., Rozman, D. (2007). Mammalian cytochromes P450—importance of tissue specificity. Biochim Biophys Acta 1770:458–466.
  • Seo, K. W., Kon, Y., Watanabe, T. (2000). Embryonic hematopoiesis defect in the tattered-Hokkaido (Tdho) mouse. Comp Med 50:27–31.
  • Shehu, A., Mao, J., Gibori, G. B., Halperin, J., Le, J., Devi, Y. S., et al. (2008). Prolactin receptor-associated protein/17beta-hydroxysteroid dehydrogenase type 7 gene (Hsd17b7) plays a crucial role in embryonic development and fetal survival. Mol Endocrinol 22:2268–2277.
  • Shen, A. L., O′Leary, K. A., Kasper, C. B. (2002). Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem 277:6536–6541.
  • Shitara, Y., Sugiyama, Y. (2006). Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112:71–105.
  • Simpson, F., Kerr, M. C., Wicking, C. (2009). Trafficking, development, and hedgehog. Mech Dev 126:279–288.
  • Smith, D. W., Lemli, L., Opitz, J. M. (1964). A newly organized syndrome of multple cogenital anomalies. J Pediatr 64:210–217.
  • Smith, M. R., Malkowicz, S. B., Chu, F., Forrest, J., Sieber, P., Barnette, K. G., et al. (2008). Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study. J Clin Oncol 26:1824–1829.
  • Solca, C., Pandit, B., Yu, H., Tint, G. S., Patel, S. B. (2007). Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse. Mol Genet Metab 91:7–14.
  • Sonoda, J., Chong, L. W., Downes, M., Barish, G. D., Coulter, S., Liddle, C., et al. (2005). Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc Natl Acad Sci U S A 102:2198–2203.
  • St-Jacques, B., Hammerschmidt, M., McMahon, A. P. (1999). Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13:2072–2086.
  • Strömstedt, M., Keeney, D. S., Waterman, M. R., Paria, B. C., Conley, A. J., Dey, S. K. (1996a). Preimplantation mouse blastocysts fail to express CYP genes required for estrogen biosynthesis. Mol Reprod Dev 43:428–436.
  • Strömstedt, M., Rozman, D., Waterman, M. R. (1996b). The ubiquitously expressed human CYP51 encodes lanosterol 14α-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch Biochem Biophys 329:73–81.
  • Sugawara, T., Fujimoto, Y., Ishibashi, T. (2001). Molecular cloning and structural analysis of human sterol C5 desaturase. Biochim Biophys Acta 1533:277–284.
  • Swinney, D. C., So, O-Y., Watson, D. M., Berry, P. W., Webb, A. S., Kertesz, D. J., et al. (1994). Selective inhibition of mammalian lanosterol 14a-demethylase by RS-2106 in vitro and in vivo. Biochemistry 33:4702–4713.
  • Taguchi, N., Rubin, E. T., Hosokawa, A., Choi, J., Ying, A. Y., Moretti, M. E., et al. (2008). Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol 26:175–177.
  • Takahashi, M. P., Kimura, T., Yanagihara, T., Sakoda, S. (1999). Calcium increase in mouse skeletal muscles by triparanol: a drug to induce myotonic dystrophy-like clinical manifestations. Neurosci Lett 272:87–90.
  • Tierney, E., Nwokoro, N. A., Porter, F. D., Freund, L. S., Ghuman, J. K., Kelley, R. I. (2001). Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet 98:191–200.
  • Tint, G. S., Yu, H., Shang, Q., Xu, G., Patel, S. B. (2006). The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J Lipid Res 47:1535–1541.
  • Tominaga, T., Kimijima, I., Kimura, M., Takatsuka, Y., Takashima, S., Nomura, Y., et al. (2010). Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial. Jpn J Clin Oncol 40:627–633.
  • Tozawa, R., Ishibashi, S., Osuga, J., Yagyu, H., Oka, T., Chen, Z., et al. (1999). Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem 274:30843–30848.
  • Tuck, S. F., Patel, H., Safi, E., Robinson, C. H. (1991). Lanosterol 14a-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol. J Lipid Res 32:893–902.
  • Ugawa, T., Kakuta, H., Moritani, H., Shikama, H. (2002). Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model. Br J Pharmacol 135:1572–1578.
  • Varjosalo, M., Taipale, J. (2008). Hedgehog: functions and mechanisms. Genes Dev 22:2454–2472.
  • Wassif, C. A., Maslen, C., Kachilelelinjewile, S., Lin, D., Linck, L. M., Connor, W. E., et al. (1998). Mutations in the human sterol Delta(7)-reductase gene at 11q12–13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 63:55–62.
  • Wassif, C. A., Zhu, P., Kratz, L., Krakowiak, P. A., Battaile, K. P., Weight, F. F., et al. (2001). Biochemical, phenotypic, and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum Mol Genet 10:555–564.
  • Waterham, H. R. (2002). Inherited disorders of cholesterol biosynthesis. Clin Genet 61:393–403.
  • Waterham, H. R. (2006). Defects of cholesterol biosynthesis. FEBS Lett 580:5442–5449.
  • Waterham, H. R., Koster, J., Romeijn, G. J., Hennekam, R. C., Vreken, P., Andersson, H. C., et al. (2001). Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69:685–694.
  • Wechsler, A., Brafman, A., Shafir, M., Heverin, M., Gottlieb, H., Damari, G., et al. (2003). Generation of viable cholesterol-free mice. Science 302:2087–2089.
  • Witsch-Baumgartner, M., Ciara, E., Loffler, J., Menzel, H. J., Seedorf, U., Burn, J., et al. (2001). Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. Eur J Hum Genet 9:45–50.
  • Witsch-Baumgartner, M., Gruber, M., Kraft, H. G., Rossi, M., Clayton, P., Giros, M., et al. (2004). Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J Med Genet 41:577–584.
  • Woollett, L. A. (1996). Origin of cholesterol in the fetal golden Syrian hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol. J Lipid Res 37:1246–1257.
  • Xie, C., Turley, S. D., Pentchev, P. G., Dietschy, J. M. (1999). Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein. Am J Physiol 276:E336–E344
  • Yoshida, S., Wada, Y. (2005). Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res 46:2168–2174.
  • Yount, NY., McNamara, DJ. (1991). Dietary regulation of maternal and fetal cholesterol metabolism in the guinea pig. Biochim Biophys Acta 1085:82–90.
  • Yu, H., Wessels, A., Tint, G. S., Patel, S. B. (2005). Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expression. Brain Res Dev Brain Res 156:46–60.
  • Zwerger, M., Kolb, T., Richter, K., Karakesisoglou, I., Herrmann, H. (2010). Induction of a massive endoplasmic reticulum and perinuclear space expansion by expression of lamin B receptor mutants and the related sterol reductases TM7SF2 and DHCR7. Mol Biol Cell 21:354–368.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.